RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Thrombosis Therapy Area Pipeline Report
Nov 2010 - 497 pages - $1,495
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
The Cardiovascular Market Outlook to 2016
Jun 2011 - 160 pages - $3,835
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2011
Oct 2011 - 47 pages - $500
Thrombotic Thrombocytopenic Purpura - Pipeline Review, Q1 2011
Mar 2011 - 32 pages - $500
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
Mar 2010 - 145 pages - $3,500
Gastrointestinal Disorders Therapy Area Pipeline Report
Nov 2010 - 933 pages - $1,495
Psychotic disorders Therapy Area Pipeline Report
Nov 2010 - 308 pages - $1,495
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Nov 2010 - 330 pages - $1,495
Insomnia and Sleep Disorders Therapy Area Pipeline Report
Nov 2010 - 527 pages - $1,495
More Related Market Research Reports >>>

Your selection

Therapeutic target
Cardiovascular del
Thrombotic disorders del
Thrombosis del
Development phase
Phase III/IV del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us